Der CJ - Search Results

1

KRAS: feeding pancreatic cancer proliferation.

Bryant KL, Mancias JD, Kimmelman AC, Der CJ. Bryant KL, et al. Among authors: der cj. Trends Biochem Sci. 2014 Feb;39(2):91-100. doi: 10.1016/j.tibs.2013.12.004. Epub 2014 Jan 2. Trends Biochem Sci. 2014. PMID: 24388967 Free PMC article. Review.

2

Understanding Ras: 'it ain't over 'til it's over'.

Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Shields JM, et al. Among authors: der cj. Trends Cell Biol. 2000 Apr;10(4):147-54. doi: 10.1016/s0962-8924(00)01740-2. Trends Cell Biol. 2000. PMID: 10740269 Review.

3

Targeting signal transduction in pancreatic cancer treatment.

Yeh JJ, Der CJ. Yeh JJ, et al. Among authors: der cj. Expert Opin Ther Targets. 2007 May;11(5):673-94. doi: 10.1517/14728222.11.5.673. Expert Opin Ther Targets. 2007. PMID: 17465725 Review.

4

Ras-driven transformation of human nestin-positive pancreatic epithelial cells.

Campbell PM, Lee KM, Ouellette MM, Kim HJ, Groehler AL, Khazak V, Der CJ. Campbell PM, et al. Among authors: der cj. Methods Enzymol. 2008;439:451-65. doi: 10.1016/S0076-6879(07)00431-4. Methods Enzymol. 2008. PMID: 18374182

5

KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.

Yeh JJ, Routh ED, Rubinas T, Peacock J, Martin TD, Shen XJ, Sandler RS, Kim HJ, Keku TO, Der CJ. Yeh JJ, et al. Among authors: der cj. Mol Cancer Ther. 2009 Apr;8(4):834-43. doi: 10.1158/1535-7163.MCT-08-0972. Mol Cancer Ther. 2009. PMID: 19372556 Free PMC article.

6

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Perou CM, Yeh JJ. Stratford JK, et al. Among authors: der cj. PLoS Med. 2010 Jul 13;7(7):e1000307. doi: 10.1371/journal.pmed.1000307. PLoS Med. 2010. PMID: 20644708 Free PMC article.

7

Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.

Vigil D, Martin TD, Williams F, Yeh JJ, Campbell SL, Der CJ. Vigil D, et al. Among authors: der cj. J Biol Chem. 2010 Nov 5;285(45):34729-40. doi: 10.1074/jbc.M110.116756. Epub 2010 Aug 27. J Biol Chem. 2010. PMID: 20801877 Free PMC article.

8

Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?

Roberts PJ, Stinchcombe TE, Der CJ, Socinski MA. Roberts PJ, et al. Among authors: der cj. J Clin Oncol. 2010 Nov 1;28(31):4769-77. doi: 10.1200/JCO.2009.27.4365. Epub 2010 Oct 4. J Clin Oncol. 2010. PMID: 20921461 Review.

9

Are all KRAS mutations created equal?

Stinchcombe TE, Der CJ. Stinchcombe TE, et al. Among authors: der cj. Lancet Oncol. 2011 Aug;12(8):717-8. doi: 10.1016/S1470-2045(11)70200-5. Epub 2011 Jul 22. Lancet Oncol. 2011. PMID: 21782508 No abstract available.

10

The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.

Neel NF, Rossman KL, Martin TD, Hayes TK, Yeh JJ, Der CJ. Neel NF, et al. Among authors: der cj. Mol Cell Biol. 2012 Apr;32(8):1374-86. doi: 10.1128/MCB.06291-11. Epub 2012 Feb 13. Mol Cell Biol. 2012. PMID: 22331470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page